To explore how cancer cell lines regulate HLA expression and whether HLA-G expression can be induced by the cytokine IFN-γ and the demethylating agent 5-aza-dC, we treated selected malignant melanoma and breast cancer cell lines with these two compounds, both individually and combined, and measured the effect on mRNA and cell surface expression levels. The gene discussed is IFNG; the disease is melanoma.